#Tomorrow, November 17, members of Syndax management will participate in a fireside chat at the UBS Global Biopharma Conference 2026.
Join us at 12:00 p.m. GMT / 7:00 a.m. EST as we highlight how we’re changing the treatment paradigm for patients in need.
Access the dial-in details below:
https://t.co/OqoWOJbKLv
A live replay will be available for a limited time.
#HappeningSoon: On Thursday, November 12 at 9:20 a.m. ET, members of Syndax leadership will take the stage during the Stifel 2026 Healthcare Conference.
Access the dial-in details below to learn how we are reimagining cancer care:
https://t.co/WajGTmrGPY
A live replay will be available for a limited time.
#MarkYourCalendars: Join members of Syndax leadership for a fireside chat on Tuesday, November 10 at 11:00 a.m. ET during the Guggenheim 3rd Annual Healthcare Innovation Conference.
Learn more about our dedication to advancing innovative cancer therapies by joining the webcast below:
https://t.co/D4KD1qRO1S
A live replay will be available for a limited time.
#NewsAlert: We are thrilled to welcome Aaron A. Ondrey to Syndax as our Chief Financial Officer.
Aaron brings decades of experience guiding biopharma companies through commercial expansion and major milestones. He will lead our financial strategy and organization as we scale our commercial business, advance our deep pipeline and deliver long-term shareholder value.
Learn more by reading our press release:
https://t.co/ChQR2apLex
Two emerging cancer therapies, daraxonrasib and revumenib, have been named to @TIME's Best Inventions of 2026 list.
From foundational scientific discoveries to clinical research, we’re proud to have helped drive the progress behind both therapies. Learn more about each breakthrough: https://t.co/zqZpy8LtwT and https://t.co/JCdZQaTUQr
Here's to an inspiring 10th Annual OneWe Reach Conference! Syndax was proud to be represented by two of our leaders in this year’s panel sessions: Nick Botwood, Chief Medical Officer and Head of R&D, and Kim Tran, SVP, Global Head of Medical.
Nick and Kim joined fellow industry experts to discuss overcoming challenges through cutting-edge technologies and research approaches, how medical affairs can shape strategic decision-making and what it takes to translate real-world evidence into meaningful results for patients.
We’re grateful for the opportunity to contribute to these critical conversations and look forward to continuing our shared work in advancing patient care.
#WeFlyHigherTogether
Last week, @ElephantsTea, a nonprofit dedicated to supporting the adolescent and young adult cancer (#AYA) community through storytelling, connection and shared experiences, released the first-ever blood cancer edition of their namesake magazine.
Syndax is proud to have sponsored this special edition, which brings together stories from people across the blood cancer community, including patients, survivors and caregivers.
Access the issue below, which features a letter from our CEO, Michael Metzger:
https://t.co/bgjl7PNqlK
#PassionforPatients #WeFlyHigherTogether
#NewsAlert: We’re thrilled to announce that 19 abstracts, including 7 oral presentations, were accepted for presentation during the 68th @ASH_hematology#ASH26 Annual Meeting.
The breadth of data accepted for presentation at ASH highlights our scientific leadership and deep commitment to advancing the standard of care for acute leukemias and chronic GVHD.
More details are available below:
https://t.co/ydhkesbnDc
What an incredible two nights at @BloodCancerUtd's Light the Night events in Boston and Manhattan!
As proud national sponsors, Syndax showed up with energy in both cities. We were honored to lead the walk in Boston and have Amanda Crolius, Associate Director of Patient Advocacy, serve as Manhattan’s Red Lantern Holder. At both locations, attendees joined us in writing messages of encouragement that will be sent to children facing cancer.
Thank you to Blood Cancer United and all of those who walked with us! Together, we helped light the path toward a brighter future for the blood cancer community.
#WeFlyHigherTogether #BloodCancerUnitedLightTheNight
During #NationalFamilyCaregiversMonth, we recognize the millions of individuals who dedicate their time, energy and hearts to caring for loved ones.
Family caregivers are the backbone of compassionate care, navigating complex challenges and putting others first every single day. We're proud to join @CaregiverAction as members of its Corporate Leadership Counsel in the ongoing work of supporting family caregivers year-round.
To all the family caregivers: your dedication does not go unnoticed. Thank you for all that you do! Find valuable caregiving resources from Caregiver Action Network and learn how #CareConnectsUs: https://t.co/Z3P0rIYNXU
#WeFlyHigherTogether
#NewsAlert: Today, we reported our third quarter 2026 financial results and provided a business update.
We delivered another quarter of strong commercial results, generating $83 million in total revenue to Syndax.
With growing revenue from two medicines, a robust pipeline generating multiple blockbuster opportunities, world-class R&D capabilities, and a strong balance sheet, Syndax is poised to deliver long-term value.
Learn more by reading our press release and joining our conference call today at 4:30 p.m. ET:
https://t.co/qgYWt8YUAj
A live replay will be available after the call for a limited time.
Last night, Revuforj® (revumenib) received an award in the “Best Product for Rare/Orphan Diseases” category during @GalienFdn's 2026 #PrixGalien USA awards ceremony.
We’re honored to be recognized by this prestigious award for our commitment to advancing groundbreaking therapies for the patient community.
Learn more:
https://t.co/AqXXkDirbz
#PassionforPatients
#MarkYourCalendars: Join us for a conference call and webcast on Monday, November 2 at 4:30 p.m. ET to hear the Syndax team discuss our third quarter 2026 financial results and provide a business update.
Click the link below for more details:
https://t.co/eFYMjBZ6KU
A live replay will be available after the call.
Tomorrow evening, we're lighting up Manhattan for @BloodCancerUtd's Light the Night!
With each step taken tomorrow, we illuminate the critical need to advance breakthrough treatments for the blood cancer community.
We'll see you under the Syndax tunnel at the finish line!
Join our team or support this important cause: https://t.co/tphzYr1BFa
#BloodCancerUnitedLightTheNight #WeFlyHigherTogether
Thrilled to announce that Revuforj® (revumenib) was named one of @TIME's Best Inventions of 2026!
We’re honored to be recognized for advancing the next generation of innovative therapies for patients who need them most. Today and always, we thank the Syndaxers, clinicians, investigators and patients who have played a pivotal role in shaping the future of medicine.
Learn more:
https://t.co/AgMDXS7HAD
#TIMEBestInventions
On #WorldMentalHealthDay, we affirm our commitment to breaking the stigma around mental health and supporting the well-being of our colleagues and the patients we serve.
After a cancer diagnosis, it is natural for feelings of distress to surface among patients and their caregivers. Today, we spotlight valuable mental wellness resources available through our partners at @BloodCancerUtd:
https://t.co/YhGmfz8xqU
#PassionforPatients #WeFlyHigherTogether
Boston, we're just one week away from @BloodCancerUtd's Light The Night!
We hope you'll join us as we walk to fund critical blood cancer research, advocate for patients and shine a ray of hope for those navigating blood cancers.
As returning national sponsors, we can’t wait to welcome you under the Syndax tunnel at the finish line!
Be the light and join our team here:
https://t.co/ihA2R0tcp6
#BloodCancerUnitedLightTheNight #WeFlyHigherTogether
Earlier this month, Syndaxers came together for our Fall Commercial Meeting in Nashville, which centered on sharing knowledge, celebrating our achievements and strengthening our commitment to the patients we serve.
The numerous panels and workshops featuring Syndax leadership and cross-functional colleagues reinforced our mission to reimagine cancer care, and the excitement for what we are delivering on was palpable.
We also learned about the promise that inspired Pinky Swear Foundation – one child’s wish to help other families facing childhood cancer, and a father who carried that wish forward. During the meeting, Syndax colleagues wrote letters of hope, strength and support to families navigating cancer through Pinky Swear’s Orange Envelope program.
Thank you to the presenters, colleagues and special guests who joined us for this incredible event!
#WeFlyHigherTogether
Patient stories have the power to inform, encourage and make a difference. As we close out #BloodCancerAwarenessMonth, we reaffirm our commitment to supporting adults, adolescent and young adults (AYAs) and pediatrics navigating #cancer.
Hear from patients and caregivers and explore the resources, support and practical insights that helped guide them through their cancer journeys:
https://t.co/5tMTkbEoex
Learn how you can join hands with the patient community by walking with Syndax during #BloodCancerUnitedLightTheNight:
https://t.co/UiZ1bboB2F
#ChaptersofCourage #PassionforPatients
Last month, members from Syndax’s Patient Advocacy and Medical team attended the Black Health Matters Harlem Week 2026 Health Summit & Expo.
We connected with attendees, engaged in meaningful conversations and discussed why awareness and representation in clinical research matters.
Thank you to Black Health Matters for including us, and to the thousands of individuals who came together to prioritize health and champion health equity.
#WeFlyHigherTogether #PassionforPatients